1-4 of 4
Ki-Ryang Koh, M.D., Ph.D.
Close
Sort by
Journal Articles

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Hideo Koh, M.D, Hirohisa Nakamae, M.D., Ph.D., Takahiko Nakane, M.D., Ph.D., Masahiro Manabe, M.D., Yoshiki Hayashi, M.D., Mitsutaka Nishimoto, M.D., Kaori Umemoto, Mika Nakamae, M.D., Ph.D., Asao Hirose, M.D., Ph.D., Eri Inoue, M.D., Atsushi Inoue, M.D., Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Ran Aimoto, M.D., Mizuki Aimoto, M.D., Yoshiki Terada, M.D., Ph.D., Ki-Ryang Koh, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D
Journal: Blood
Blood (2010) 116 (21): 3551.
https://doi.org/10.1182/blood.V116.21.3551.3551
Published: 2010
Journal Articles

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Ran Moriguchi, M.D., Mizuki Aimoto, M.D., Yuki Akazawa, M.D., Eri Wada, M.D., Hiroshi Kanashima, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Ki-Ryang Koh, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Yoshitaka Nakao, M.D., Ph.D., Hirofumi Teshima, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 4456.
https://doi.org/10.1182/blood.V110.11.4456.4456
Published: 2007
Journal Articles

Non-TBI, Non-ATG Containing Fludarabine-Based Regimen for Unrelated Allogeneic Reduced Intensity Transplantation.

Hirohisa Nakamae, MD, PhD, Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takaoka, M.D.,Ph.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.
Journal: Blood
Blood (2006) 108 (11): 5382.
https://doi.org/10.1182/blood.V108.11.5382.5382
Published: 2006
Journal Articles

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Takahiko Nakane, MD, Hirohisa Nakamae, M.D.,Ph.D., Hiroshi Kamoi, M.D.,Ph.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2915.
https://doi.org/10.1182/blood.V108.11.2915.2915
Published: 2006